Combined Impact of Triglyceride–Glucose Index and Alanine Aminotransferase on Steatotic Liver Disease and Subtypes
Journal of Gastroenterology and Hepatology · 2026-03 · 41 (3) · 1030-1040
DOI: 10.1111/jgh.70258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 28.01.2026. Verfasst von Yu-Jin Kwon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea. Hauptthemen laut MEDLINE: Triglycerides, Blood Glucose, Alanine Transaminase, Fatty Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry, National Research Foundation of Korea.
Abstract (Originalsprache)
Background and Aim The triglyceride–glucose (TyG) index and alanine aminotransferase (ALT) are emerging biomarkers linked to metabolic disturbances and liver health. Nonetheless, the combined impact of these markers on predicting new‐onset steatotic liver disease (SLD) and its metabolic and alcohol‐associated subtypes remains unclear. This study aimed to investigate the association of TyG and ALT, individually and combined, in incident SLD in the Korean Genome and Epidemiology Study (KoGES) and UK Biobank cohorts.
Methods
This study utilized data from two large population‐based cohorts: KoGES (adults aged 40–69 years from South Korea [2001–2002]) and UK Biobank (participants aged 37–73 years from the United Kingdom [2006–2010]). Participants without baseline SLD were classified into four groups based on TyG index and ALT levels, and the incidence of SLD was compared among these groups to assess risk.
Results
Elevated baseline TyG index and ALT levels were significantly associated with a higher risk of new‐onset SLD and its subtypes in both cohorts. The highest HRs and ORs were observed in individuals with both markers elevated (2.39 in KoGES; 3.89 in UK Biobank). Survival analyses confirmed significantly lower survival probabilities in high‐risk groups ( p < 0.001). Predictive accuracy was highest with the combined TyG index + ALT model, outperforming either marker alone ( p < 0.001).
Conclusions
Elevated combined baseline TyG index and ALT levels were significantly associated with increased risk of SLD and its subtypes. Combined use of these markers may be valuable for early identification and risk stratification of individuals at risk for SLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Family Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.
- Department of Family Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Biostatistics Collaboration Unit, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Republic of Korea.
ORCID-Profile: Yu-Jin Kwon, Minhong Kim, Seok-Jae Heo, Ji-Won Lee
Förderung
- Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry
- National Research Foundation of Korea
Zitieren
APA
Kwon, Y. J., Kim, M., Heo, S. J., & Lee, J. W. (2026). Combined Impact of Triglyceride–Glucose Index and Alanine Aminotransferase on Steatotic Liver Disease and Subtypes. Journal of Gastroenterology and Hepatology, 41(3), 1030-1040. https://doi.org/10.1111/jgh.70258
Vancouver
Kwon YJ, Kim M, Heo SJ, Lee JW. Combined Impact of Triglyceride–Glucose Index and Alanine Aminotransferase on Steatotic Liver Disease and Subtypes. Journal of Gastroenterology and Hepatology. 2026;41(3):1030-1040. doi:10.1111/jgh.70258
BibTeX
@article{Kwon2026,
author = {Kwon, Yu-Jin and Kim, Minhong and Heo, Seok-Jae and Lee, Ji-Won},
title = {Combined Impact of Triglyceride–Glucose Index and Alanine Aminotransferase on Steatotic Liver Disease and Subtypes},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {41},
number = {3},
pages = {1030--1040},
doi = {10.1111/jgh.70258}
}
EUVIMED